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INTRODUCTION
The evolution of oncoplastic breast surgery, par-
ticularly reduction therapeutic mammoplasty (TM) 
procedures, has grown over the years due to the 
demand for more aesthetically acceptable results.1–9 
Furthermore, patients with redundant breast skin 
envelopes have benefited from utilizing the lower 
breast pole de-epithelized skin [dermal flap (DF)] in 
providing additional coverage to protect the prosthe-
sis in implant-based breast reconstruction with more 
predictable outcomes.10,11 Notably, the tenets of the 
multidisciplinary thoracic oncoplastic approach are 
ostensibly established in the literature gaining more 
popularity driven by high level of patient satisfac-
tion.12–14 Acknowledging the advantages of both tech-
niques (TM and DF), the authors have principally 
combined them to achieve a novel hybrid approach 
for chest wall reconstruction postresection of primary 
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Background: Breast reduction techniques in management of breast cancer have 
been described since 1980 mainly to resect a large tumor in large breasts. Driven 
by the demand for more aesthetically acceptable results without compromising 
oncological safety, these oncoplastic approaches have become more popular. In 
addition, the utilization of redundant lower pole dermal flap has been a widely 
practiced tool in the armamentarium of implant-based breast reconstruction in 
patients with large ptotic breasts. The authors advocate a novel hybrid technique 
utilizing both therapeutic mammoplasty and lower breast pole dermal flap to pro-
vide coverage for anterior chest wall defect posttumor resection in patients with 
large or ptotic breasts.
Methods: A retrospective review was conducted on patients who underwent chest 
wall resection and reconstruction using therapeutic mammoplasty and dermal flap 
to provide soft tissue coverage in the period between 2012 and 2018. Patient’s 
demographics, clinicopathological, radiological, operative details, postoperative 
morbidity, and follow-up data were recorded.
Results: Nine patients with chondrosarcoma (7/9) and giant cell tumor (2/9) 
were managed with a mean age 44.1 years (range 28–73). Complete oncological 
resection was achieved in all patients followed by rigid/nonrigid skeletal recon-
structions. All procedures were completed successfully with no nipple areolar com-
plex (NAC) necrosis or prosthesis failure experienced during the follow-up period 
(range 12–72 months). Excellent functional and aesthetic outcomes were reported 
in all patients.
Conclusion: The authors’ results demonstrate that this technique could be safely 
planned for soft tissue coverage postchest wall resection with superior aesthetic 
and durable outcomes. (Plast Reconstr Surg Glob Open 2020;8:e2593; doi: 10.1097/
GOX.0000000000002593; Published online 23 March 2020.)
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chest wall tumors (CWTs). This would improve the 
functional and aesthetic results without jeopardizing 
the oncological outcome. This article describes the 
technique and the outcome which to the authors’ best 
of knowledge would the first time to describe in this 
context.
MATERIALS AND METHODS
Prospectively collected data from 9 consecutive 
patients in the period between January 2012 and June 
2018 were reviewed and assessed retrospectively. The indi-
cations included women with moderate or large breasts 
presenting with an anteriorly located primary CWT. They 
were managed through a thoracic oncoplastic multidis-
ciplinary team approach to optimize their perioperative 
treatment plan.
The patients’ demographics, comorbidities, tumor 
characteristics, and the radiological diagnostic work-up 
were documented. The operative details, postoperative 
outcomes, patient’s satisfaction survey, and follow-up were 
recorded. The 2-team single-stage approach for surgical 
resection and reconstruction for CWT using TM and DF 
is demonstrated in Figures 1–4 (see figure, Supplemental 
Digital Content 1, which displays: (A) preoperative photo-
graph for a 34-year-old patient [body mass index (BMI): 
40 and active smoker] with breast cup size J and grade III 
ptosis. B, Intraoperative photograph demonstrating the 
anterior chest wall defect (300 cm2) post en-bloc resection 
of tumor and adjacent ribs exposing the intrathoracic vis-
cera and diaphragm. Note the rigid skeletal reconstruction 
using methylmethacrylate mesh (MMM) in preparation to 
be secured to the edge of the defect. Of note, a superome-
dial NAC pedicle was designed with breast tissue of 700 g 
resected from each side. C, Intraoperative photograph 
demonstrating the insetting of the inferiorly based DF over 
the MMM and suture of its cephalic free border to the 
inferolateral edge of the pectoralis major muscle, thus pro-
viding complete coverage of the mesh. D, Intraoperative 
photograph postwound closure and applying Incision neg-
ative pressure wound therapy (iNPWT) (Prevena Dressing; 
Kinetic Concepts, Inc., San Antonio, Tex.) to promote 
healing in this high-risk wound due to risk factors (BMI 
40 and active smoker). E, Postoperative photograph 24 
months showing healing of scars with primary intention, 
complete survival of the NAC on both sides with satisfactory 
shape and symmetry of both breasts, http://links.lww.com/
PRSGO/B342).
(See Video [online], which displays the multidisci-
plinary two-team approach for en-bloc resection of a 
right anterior chest wall chondrosarcoma in a 29-year-old 
patient. Strattice ADM was used to restore the skeletal 
chest wall integrity, while soft tissue coverage was achieved 
using the wise pattern TM and DF with simultaneous con-
tralateral symmetrization reduction mammoplasty.)
RESULTS
The patient and tumor characteristics, operative 
details, follow-up period, and outcomes are summarized 
in Table 1. Their age ranged from 28 to 73 years (mean 
44.1), whereas the BMI ranged from 27 to 41 kg/m2 (mean 
32.7). Chondrosarcoma was the commonest pathology 
(7/9), whereas giant cell tumor was in (2/9) cases. A 
wise pattern approach TM was performed in all patients. 
The superomedial NAC pedicle was the commonest per-
formed (6/9) followed by superior pedicle (2/9) and 
superolateral (1/9). Breast tissue was resected in 66.6% 
(6/9) of the patients at the primary surgery with a range 
of 56–1,200 g (mean 424), whereas 33% (3/9) required 
only mastopexy. Contralateral breast symmetrization was 
performed in (7/9) [6 reductions and 1 mastopexy] [5/7 
simultaneously and 2/7 subsequent second stage]. The DF 
was inferiorly based on all patients except one which was 
superiorly based due to the location of the tumor caudal to 
the inframammary fold. The numbers of the ribs resected 
were between 2 and 4 (median 3) with resultant defect size 
ranged from 90 to 300cm2 (mean 138). Adequate clear 
surgical margins were achieved in all patients. The resul-
tant defect was repaired using MMM in (5/9), acelluar 
dermal matrix (Strattice, Lifecell, Allergan, N.J.) in (2/9), 
and polyprolene mesh (PPM) in (2/9). iNPWT (Prevena 
dressing) was used in high-risk patients (3/9) due to mor-
bid obesity, diabetes, and smoking. During the follow-up 
Fig. 1. a 47-year-old patient with a giant cell tumor in the anterior left chest wall. a, preoperative photo 
showing breasts, cup size C, with grade III ptosis. B, Ct scan of the thorax revealing a giant cell tumor of 
the left fourth rib in midclavicular line.
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period of 12–72 months (median 31), there was no local 
recurrence or mortality experienced. One patient expe-
rienced a superficial T junction breakdown which was 
managed conservatively; no surgical site infection (SSI) 
was encountered. All patients experienced complete 
survival of NAC with excellent functional and aesthetic 
results and high satisfaction rates.
DISCUSSION
The patient-driven evolution of the oncoplastic reduc-
tion mammoplasty for the management of breast can-
cer has, respectively, become popularized over the past 
2 decades due to the demand for better functional and 
aesthetic results.1–8 Furthermore, more recent studies have 
broadened the indications and introduced the concept of 
extreme oncoplasty technique for management of locally 
advanced breast cancer.9 Along these lines, the authors 
advocated similar approach to manage female patients 
with anterior chest wall chondrosarcoma and giant cell 
tumors. Notably, these patients have excellent disease-free 
and survival rates with surgery considered the cornerstone 
of their management.15 Nevertheless, chest wall resection 
and reconstruction using conventional methods could be 
debilitating with less favorable functional and aesthetic 
outcomes.16 The ideal patient would be one with a moder-
ate or large breast who will benefit from reduction or mas-
topexy with a moderate anterior chest wall skeletal defect 
post tumor extipiration. In this study, the majority of the 
patients were young and active, preferring a less invasive 
approach with attention to the aesthetic results without 
compromising the oncological outcome. Similarly, previ-
ous studies demonstrated the concept for providing the 
opportunity to design incisions that provide muscle spar-
ing approaches and more aesthetically acceptable results 
with improvement of patient’s satisfaction and overall 
quality of life.14,17,18 We have previously demonstrated the 
value and importance of the multidisciplinary approach 
for chest wall resection and reconstruction to provide 
complete well-vascularized coverage to minimize the 
SSI.14,19 A step ahead is to achieve this goal with muscle 
sparing approach avoiding functional deficit with better 
quality of life. DF has proven to be valuable in coverage 
of breast implants for breast reconstruction.10,11 Hence, 
we combined DF with TM as a muscle sparing approach 
to provide coverage and protection of the prosthesis 
used for either rigid or nonrigid skeletal reconstruc-
tion. Acknowledging the well-established indications for 
iNPWT reported in the literature,20 we have extended its 
application in thoracic oncoplasty procedures, which has 
proved to be valuable in high-risk patients. Although the 
most significant finding in this series is that all patients’ 
treatment was completed without any SSI or NAC necrosis, 
there are limitations to this study due to its retrospective 
nature, single-center experience with small sample size, 
and the relatively medium follow-up period. The proxi-
mate collaboration between thoracic and oncoplastic sur-
geons to achieve a satisfactory oncological outcome along 
with the best aesthetic results is imperative. Therefore, the 
authors believe that this multidisciplinary approach could 
Fig. 2. Intraoperative photograph demonstrating the wise pat-
tern tM approach with superior pedicle naC and de-epithelization 
inferior breast pole skin to create an inferiorly based dF. note the 
nonrigid skeletal reconstruction for the anterior chest wall defect 
(150 cm2) with PPM post en bloc resection of tumor and adjacent ribs.
Fig. 3. Intraoperative photograph demonstrating the insetting of 
the inferiorly based dF over the PPM and suture of its cephalic free 
border to the inferolateral edge of the pectoralis major muscle thus 
providing complete coverage of the mesh. note the superior pedi-
cled naC that will be transposed to its new position as part of the 
Wise pattern mastopexy.
Fig. 4. Postoperative photograph 18 months after the second-stage 
right contralateral symmetrization mastopexy showing healing of 
scars with primary intention, complete survival of the naC on both 
sides with good shape and symmetry of both breasts.
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be added to the repertoire of techniques described in the 
literature for chest wall resection and reconstruction. It is 
safe, less invasive with superior aesthetic and functional 
outcome, and better quality of life when compared to con-
ventional approaches.
Haitham H. Khalil, MSc, MRCS(Ed), MD, FRCS(Eng)
Consultant Oncoplasty and Reconstructive Surgeon
Plastic and Reconstructive Surgery Division
Good Hope Hospital
University Hospitals Birmingham Trust
Sutton Coldfield
Birmingham B75 7RR, West Midlands, UK
E-mail: haitham.khalil@heartofengland.nhs.uk
ACKNOWLEDGMENT
The authors thank Jamie Ryan-Ainslie and the entire Medical 
Illustration Team at University Hospitals Birmingham (UHB) 
for their expert input.
REFERENCES
 1. Clough KB, Lewis JS, Couturaud B, et al. Oncoplastic techniques 
allow extensive resections for breast-conserving therapy of breast 
carcinomas. Ann Surg. 2003;237:26–34. 
 2. Losken A, Pinell XA, Eskenazi B. The benefits of partial versus 
total breast reconstruction for women with macromastia. Plast 
Reconstr Surg. 2010;125:1051–1056. 
 3. Clough KB, Kroll SS, Audretsch W. An approach to the 
repair of partial mastectomy defects. Plast Reconstr Surg. 
1999;104:409–420. 
 4. Losken A, Hart AM, Broecker JS, et al. Oncoplastic breast reduc-
tion technique and outcomes: an evolution over 20 years. Plast 
Reconstr Surg. 2017;139:824e–833e. 
 5. McCulley SJ, Macmillan RD. Planning and use of therapeu-
tic mammoplasty–Nottingham approach. Br J Plast Surg. 
2005;58:889–901. 
 6. McCulley SJ, Durani P, Macmillan RD. Therapeutic mamma-
plasty for centrally located breast tumors. Plast Reconstr Surg. 
2006;117:366–373. 
 7. McCulley SJ, Macmillan RD. Therapeutic mammaplasty–analysis 
of 50 consecutive cases. Br J Plast Surg. 2005;58:902–907. 
 8. Schaverien MV, Raine C, Majdak-Paredes E, et al. Therapeutic 
mammaplasty–extending indications and achieving low incom-
plete excision rates. Eur J Surg Oncol. 2013;39:329–333. 
 9. Silverstein MJ, Savalia N, Khan S, et al. Extreme oncoplasty: 
breast conservation for patients who need mastectomy. Breast J. 
2015;21:52–59. 
 10. Hammond DC, Capraro PA, Ozolins EB, et al. Use of a skin-spar-
ing reduction pattern to create a combination skin-muscle flap 
pocket in immediate breast reconstruction. Plast Reconstr Surg. 
2002;110:206–211. 
 11. Goyal A, Wu JM, Chandran VP, et al. Outcome after autologous 
dermal sling-assisted immediate breast reconstruction. Br J Surg. 
2011;98:1267–1272. 
 12. Gonfiotti A, Santini PF, Campanacci D, et al. Malignant primary 
chest-wall tumours: techniques of reconstruction and survival. 
Eur J Cardiothorac Surg. 2010;38:39–45. 
 13. Mansour KA, Thourani VH, Losken A, et al. Chest wall resec-
tions and reconstruction: a 25-year experience. Ann Thorac Surg. 
2002;73:1720–1725; discussion 1725. 
 14. Khalil HH, Malahias MN, Balasubramanian B, et al. 
Multidisciplinary oncoplastic approach reduces infection in 
chest wall resection and reconstruction for malignant chest wall 
tumors. Plast Reconstr Surg Glob Open. 2016;4:e809. 
 15. Fromm J, Klein A, Baur-Melnyk A, et al. Survival and prognostic 
factors in conventional central chondrosarcoma. BMC Cancer. 
2018;18:849. 
 16. Moscona RA, Fodor L, Ben-Nun A, et al. Never say no to a dam-
aged muscle: the applications of previously damaged pectoralis 
major and latissimus dorsi muscles for chest wall reconstruction. 
Ann Plast Surg. 2006;56:156–159. 
 17. Basta MN, Fischer JP, Lotano VE, et al. The thoracoplastic 
approach to chest wall reconstruction: preliminary results of a 
multidisciplinary approach to minimize morbidity. Plast Reconstr 
Surg. 2014;134:959e–967e. 
 18. Hamdi M, Dancey A. The septum-based therapeutic mamma-
plasty technique for management of sternal defects. Plast Reconstr 
Surg. 2010;125:569–573. 
 19. Khalil HH, Kalkat M, Malahias MN, et al. Chest wall reconstruc-
tion with porcine acellular dermal matrix (Strattice) and autolo-
gous tissue transfer for high risk patients with chest wall tumors. 
Plast Reconstr Surg Glob Open. 2018;6:e1703. 
 20. Webster J, Liu Z, Norman G, et al. Negative pressure wound 
therapy for surgical wounds healing by primary closure. Cochrane 
Database Syst Rev. 2019;3:CD009261. 
